The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States
Abstract
Objective: This study aims to investigate the association between the hemoglobin A1c (HbA1c)/high-density lipoprotein cholesterol (HDL-C) ratio and incident cardiometabolic multimorbidity (CMM) among adults aged 50 years and older. Methods: This study analyzed data from wave 2 (2004) to wave 11 (2022) of the English Longitudinal Study of Ageing (ELSA) and wave 8 (2006) to wave 16 (2022) of the Health and Retirement Study (HRS). The independent variables included cumulative HbA1c/HDL-C ratio, its value at first visit, and its trajectory identified by group-based trajectory modeling (GBTM). The association between the HbA1c/HDL-C ratio and the risk of CMM was assessed using Kaplan–Meier curves, multivariable Cox regression analysis, and restricted cubic spline (RCS) models. Its incremental predictive value was also evaluated. Additionally, mediation analyses, subgroup analyses, and sensitivity analyses were further employed. Results: Among the 5,226 participants included, CMM developed in 303 of 1,918 participants (15.8%) in ELSA and in 283 of 3,308 participants (8.8%) in HRS. After adjusting for confounders, each 1-standard deviation (SD) increase in the cumulative HbA1c/HDL-C ratio and the value at first visit HbA1c/HDL-C ratio was significantly associated with a higher risk of CMM [pooled hazard ratio (HR): 1.33, 95% confidence interval (CI): 1.19–1.47, p < 0.001; pooled HR: 1.24, 95% CI: 1.07–1.43, p = 0.004]. Individuals in the persistently high HbA1c/HDL-C ratio group had a 100% higher risk of developing CMM than those in the persistently low group (pooled HR: 2.00, 95% CI: 1.45–2.74, p < 0.001). Linear associations were identified between the cumulative HbA1c/HDL-C ratio and incident CMM in ELSA and HRS, as well as between the HbA1c/HDL-C ratio and incident CMM at first visit in HRS (all p for overall <0.05 and p for non-linearity >0.05). The addition of the HbA1c/HDL-C ratio significantly improves the predictive ability of the basic model. The relationship between the trajectory of the HbA1c/HDL-C ratio and incident CMM was partially mediated by BMI in HRS. The results from sensitivity analyses and subgroup analyses aligned with the main findings. Conclusion: Significant linear associations were identified between increases in the HbA1c/HDL-C ratio and the risk of incident CMM among middle-aged and older adults from the United Kingdom (UK) and the United States (US). Persistent monitoring and maintenance of favorable levels of HbA1c/HDL-C ratio may contribute to the early detection and effective prevention of CMM development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“Low HDL-C fails to efficiently remove oxidative byproducts, further aggravating vascular injury (61, 62).”
Association between sleep duration and cognitive decline
Ma, Y., Liang, L., Zheng, F., Shi, L., Zhong, B., & Xie, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13573 · Cited by 535
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Parhofer, K. G. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.353 · Cited by 458
Inflammation and metabolic cardiomyopathy
Nishida, K., & Otsu, K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx012 · Cited by 329
Modification of lipoprotein metabolism and function driving atherogenesis in diabetes
Luciani, L., Pedrelli, M., & Parini, P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117545 · Cited by 72 · cited 1×
“In addition, previous studies have demonstrated a J-shaped association between HbA1c and both cardiovascular disease (CVD) and all-cause mortality, with HbA1c levels above 8.0% being associated with an elevated risk of CVD and death (16).”
InfluentialDifferent hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts
Ma, Y., Hua, R., Yang, Z., Zhong, B., Yan, L., & Xie, W. (2021) · BMC Medicine · doi:10.1186/s12916-021-02165-4 · Cited by 64
Research works printed but not linked: 57
- Miranda, 2019, Understanding the rise of cardiometabolic diseases in low- and middle-income countries, Nat Med, 25, 1667, 10.1038/s41591-019-0644-7 · DOI · Paper page
- Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, 52
- Cheng, 2022, Trends in the prevalence of Cardiometabolic multimorbidity in the United States, 1999-2018, Int J Environ Res Public Health, 19, 4726, 10.3390/ijerph19084726 · DOI
- Otieno, 2023, Cardiometabolic multimorbidity associated with moderate and severe disabilities: results from the study on global AGEing and adult health (SAGE) wave 2 in Ghana and South Africa, Glob Heart, 18, 9, 10.5334/gh.1188 · DOI
- Dove, 2023, Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry, Eur Heart J, 44, 573, 10.1093/eurheartj/ehac744 · DOI
- Dove, 2023, Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression, Alzheimers Dement, 19, 821, 10.1002/alz.12708 · DOI
- Huang, 2019, Cardiometabolic multimorbidity and depression in adults aged 45 years and older in China: longitudinal findings from the China health and retirement longitudinal study, Lancet, 394, S89, 10.1016/s0140-6736(19)32425-0 · doi:10.1016/s0140-6736(19)32425-0
- Canoy, 2021, Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices, BMC Med, 19, 258, 10.1186/s12916-021-02126-x · DOI
- Liu, 2025, Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiometabolic multimorbidity among middle-aged and older adults in China, BMC Public Health, 25, 570, 10.1186/s12889-025-21757-w · DOI
- Liu, 2024, Association of Visceral Adiposity Index and Handgrip Strength with Cardiometabolic multimorbidity among middle-aged and older adults: findings from Charls 2011-2020, Nutrients, 16, 2277, 10.3390/nu16142277 · DOI
- Hu, 2021, Association between the plasma-glycosylated hemoglobin A1c/high-density lipoprotein cholesterol ratio and carotid atherosclerosis: a retrospective study, J Diabetes Res, 9238566, 10.1155/2021/9238566 · DOI
- He, 2024, The newly proposed plasma-glycosylated hemoglobin A1c/high-density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population, BMC Gastroenterol, 24, 274, 10.1186/s12876-024-03362-0 · DOI
- Wang, 2024, Correlation between glycolipid metabolism levels and diabetic retinopathy in patients with type 2 diabetes mellitus, DMSO, 17, 1, 10.2147/DMSO.S437586 · DOI
- Balintescu, 2019, Hemoglobin A1c and permissive hyperglycemia in patients in the intensive care unit with diabetes, Crit Care Clin, 35, 289, 10.1016/j.ccc.2018.11.010 · DOI
- Wan, 2016, Association of hemoglobin A1c levels with cardiovascular disease and mortality in Chinese patients with diabetes, J Am Coll Cardiol, 67, 456, 10.1016/j.jacc.2015.11.020 · doi:10.1016/j.jacc.2015.11.020
- Mineo, 2012, Novel biological functions of high-density lipoprotein cholesterol, Circ Res, 111, 1079, 10.1161/CIRCRESAHA.111.258673 · DOI · Paper page
- 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619 · DOI · Paper page
- Sonnega, 2014, Cohort profile: the health and retirement study (HRS), Int J Epidemiol, 43, 576, 10.1093/ije/dyu067 · DOI · Paper page
- Steptoe, 2013, Cohort profile: the English longitudinal study of ageing, Int J Epidemiol, 42, 1640, 10.1093/ije/dys168 · DOI · Paper page
- Dong, 2025, Association of HbA1c/HDL-C ratio and depression with cardiometabolic multimorbidity in middle-aged and older adults: a nationwide prospective cohort study, Front Nutr, 12, 1642243, 10.3389/fnut.2025.1642243 · DOI
- Huang, 2025, Association between the hemoglobin A1c/high-density lipoprotein cholesterol ratio and stroke incidence: a prospective nationwide cohort study in China, Lipids Health Dis, 24, 25, 10.1186/s12944-025-02438-4 · DOI
- Lu, 2025, Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study, Cardiovasc Diabetol, 24, 202, 10.1186/s12933-025-02754-0 · DOI
- Zhang, 2025, Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in China and the United States, Cardiovasc Diabetol, 24, 51, 10.1186/s12933-025-02575-1 · DOI
- Lv, 2025, The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study, Cardiovasc Diabetol, 24, 358, 10.1186/s12933-025-02919-x · DOI
- Ruan, 2025, Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study, Cardiovasc Diabetol, 24, 382, 10.1186/s12933-025-02939-7 · DOI · Paper page
- Nagin, 2010, Group-based trajectory modeling in clinical research, Annu Rev Clin Psychol, 6, 109, 10.1146/annurev.clinpsy.121208.131413 · DOI · Paper page
- Yu, 2020, Association between visit-to-visit variability of HbA1c and cognitive decline: a pooled analysis of two prospective population-based cohorts, Diabetologia, 63, 85, 10.1007/s00125-019-04986-8 · DOI
- VanderWeele, 2017, Sensitivity analysis in observational research: introducing the E-value, Ann Intern Med, 167, 268, 10.7326/M16-2607 · DOI · Paper page
- Marco, 2025, Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes, Diabetes Res Clin Pract, 224, 112189, 10.1016/j.diabres.2025.112189 · DOI
- Mo, 2025, Cholesterol, high-density lipoprotein, and glucose index versus triglyceride–glucose index in predicting cardiovascular disease risk: a cohort study, Cardiovasc Diabetol, 24, 116, 10.1186/s12933-025-02675-y · DOI
- Ding, 2018, Hemoglobin A1c and diagnosis of diabetes, J Diabetes, 10, 365, 10.1111/1753-0407.12640 · DOI
- Mitsios, 2018, Relationship between glycated hemoglobin and stroke risk: A systematic review and Meta-analysis, J Am Heart Assoc, 7, e007858, 10.1161/JAHA.117.007858 · DOI
- Li, 2024, The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: a cohort study, Diabetes Res Clin Pract, 213, 111751, 10.1016/j.diabres.2024.111751 · DOI
- Khaw, 2006, Glycated hemoglobin as a marker of cardiovascular risk, Curr Opin Lipidol, 17, 637, 10.1097/mol.0b013e3280106b95 · DOI
- Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 · DOI · Paper page
- Chapman, 2006, Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease, Pharmacol Ther, 111, 893, 10.1016/j.pharmthera.2006.02.003 · DOI
- Castelli, 1986, Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study, JAMA, 256, 2835, 10.1001/jama.1986.03380200073024 · DOI · Paper page
- Chen, 2024, Differences in HDL-related coronary heart disease risk between individuals with and without diabetes, Atherosclerosis, 397, 118553, 10.1016/j.atherosclerosis.2024.118553 · DOI
- Amarenco, 2008, High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review, Atherosclerosis, 196, 489, 10.1016/j.atherosclerosis.2007.07.033 · DOI · Paper page
- Hu, 2023, The association between HDL-C and stroke in the middle-aged and elderly: A cross-sectional study, Brain Behav, 13, e2901, 10.1002/brb3.2901 · DOI
- Barter, 2007, HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events, N Engl J Med, 357, 1301, 10.1056/NEJMoa064278 · DOI · Paper page
- Kashyap, 2018, Glycation reduces the stability of ApoAI and increases HDL dysfunction in diet-controlled type 2 diabetes, J Clin Endocrinol Metab, 103, 388, 10.1210/jc.2017-01551 · DOI
- Zhou, 2025, Relationship of METS-IR with cardiometabolic multimorbidity in China: a nationwide longitudinal cohort study, Front Nutr, 12, 1518840, 10.3389/fnut.2025.1518840 · DOI
- Liu, 2025, Association between the CHG index and cardiometabolic multimorbidity: a nationwide prospective cohort and multi-community cross-sectional study, Front Nutr, 12, 1725495, 10.3389/fnut.2025.1725495 · DOI
- He, 2026, Association between the cumulative atherogenic index of plasma and cardiometabolic multimorbidity: the mediating effects of the TyG index and body mass index, Lipids Health Dis, 25, 65, 10.1186/s12944-026-02875-9 · DOI
- Zheng, 2025, Association between glycated hemoglobin/high-density lipoprotein ratio and nonalcoholic fatty liver disease in a U.S. nondiabetic population: a cross-sectional study based on NHANES 2017-2020 data, BMC Gastroenterol, 25, 567, 10.1186/s12876-025-04190-6 · DOI
- Wu, 2025, The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017-2020), BMC Gastroenterol, 25, 369, 10.1186/s12876-025-03974-0 · DOI
- Zeng, 2025, The association between HbA1c/HDL-C and the incidence of cardiometabolic multimorbidity in middle-aged and elderly adults: results from the China health and retirement longitudinal study, PLoS One, 20, e0332376, 10.1371/journal.pone.0332376 · DOI
- Hendriks, 2020, Alcohol and human health: what is the evidence?, Annu Rev Food Sci Technol, 11, 1, 10.1146/annurev-food-032519-051827 · DOI · Paper page
- Shi, 2017, Macro- and microvascular endothelial dysfunction in diabetes, J Diabetes, 9, 434, 10.1111/1753-0407.12521 · DOI · Paper page
- Sharma, 2024, Association of biomarkers for dyslipidemia, inflammation, and oxidative stress with endothelial dysfunction in obese youths: a case–control study, DMSO, 17, 2533, 10.2147/DMSO.S458233 · DOI
- Škrha, 2016, Glucose variability, HbA1c and microvascular complications, Rev Endocr Metab Disord, 17, 103, 10.1007/s11154-016-9347-2 · DOI
- Sun, 2025, Methylglyoxal mediates the association between 2-hour plasma glucose and HbA1c with inflammation: the Maastricht study, J Clin Endocrinol Metab, 110, 2047, 10.1210/clinem/dgae640 · DOI
- Adorni, 2021, High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives, Cells, 10, 574, 10.3390/cells10030574 · DOI
- Chen, 2022, Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy, J Mol Med, 100, 1721, 10.1007/s00109-022-02269-1 · DOI
- Silveira Rossi, 2022, Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors, Diabetes Metab Res Rev, 38, e3502, 10.1002/dmrr.3502 · DOI · Paper page
- Mr, 2005, Type 2 diabetes as a lipid disorder, Curr Mol Med, 5, 297, 10.2174/1566524053766086 · DOI · Paper page
Metadata
- Authors
- Ji, H., Zhao, Z., Li, R., Ma, W., Zhang, M., & Zhou, Z.
- Venue
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Published
- 2026-06-29
- Volume
- 13
- ISSN
- 2296-861X
- Cited by
- 0
- References
- 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States. https://app.cochat.ai/papers/10.3389/fnut.2026.1849520
- The paper
- Ji, H., Zhao, Z., Li, R., Ma, W., Zhang, M., & Zhou, Z. (2026). The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2026.1849520
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.